Dr. Loh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ventura Heart Institute
555 Marin Street, Suite 210
Thousand Oaks, CA 91360Phone+1 805-576-7533Fax+1 818-702-0080- Is this information wrong?
Summary
- Board certified internist & subspecialty certified cardiac specialist - emphasis preventive cardiology. Original cardiology consultant Doximity. Founded & directed Ventura Heart Institute (education, research & preventive cardiovascular programs). Former Asst Prof Med UCLA School of Medicine & former Asst Clin Prof Med UC Irvine. Former Adjunct Lecturer, Stanford Univ School of Medicine. Member of 2 AI4H Working Groups (AI for symptom assessment) (AI for Clinical Evaluation)/World Health Organization. UC Berkeley (PBK as junior), MD UC San Francisco (Regents Scholar; AOA as junior), Internal Medicine Residency UCSF. Lipid research National Heart, Lung & Blood Institute at National Institutes of Health (NIH) in both intramural (Molecular Diseases/Lipid Metabolism Branch) & extramural (Cardiac Diseases Branch; Division of Heart & Vascular Diseases) divisions. Faculty in both Departments of Cardiology & Cardiac Surgery at Cedars-Sinai. Chaired HCA Los Robles Hospital IRB, founded BioEthics Committee, directed echocardiography lab. Principal investigator on over 160 cardiovascular clinical trials (primarily phase 1, 2, 3 trials). In 1987, wrote a bespoke electronic health record system. Presenter at RAND, USC School of Business, UCLA Anderson School of Business, Mayo Clinic - Rochester MN, both UC Berkeley Center for Information Technology Research in the Interest of Society & School of Public Health & at Harvard School of Public Health. TEDx Lecturer (http://youtu.be/b51KhIy3cA0) on how medical advances are validated. Past Chief Medical Advisor to Confideo Lab/DoctorVirtualis (virtual reality), Senior Advisor MORE Health, prior Lead Contributor - Sermo Cardiology Hub. Past Chair of Technology Committee of CA Chapter of ACC, Co-founder & CMO of Infermedica (artificial intelligence). Member - Global Panel/MIT Tech Review. CTeL Coalition Leadership (Telehealth4Ukraine.org). Advisor, health tech start-ups. Senior Consultant, Care Access (decentralized clinical trials)
Education & Training
- Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1979
- National Institutes of Health Clinical CenterPost-Doctoral Fellowship, Research, 1974 - 1977
- University of California (San Francisco)Residency, Internal Medicine, 1974
- University of California San Francisco School of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1974 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow, American College of Cardiology (FACC) American College of Cardiology
- Fellow, American Heart Association (Epidemiology & Prevention) American Heart Association
- Fellow, American College of Chest Physicians American College of Chest Physicians
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAdvancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.Sherry-Ann Brown, Craig Beavers, Brenton Bauer, Richard K Cheng, Generika Berman
American Heart Journal Plus. 2024-02-01 - 497 citationsEffects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.John F. Brensike, Robert I. Levy, S. F. Kelsey, Eugene R. Passamani, John M. Richardson
Circulation. 1984-02-01 - 30 citationsNational heart, lung, and blood institute type II coronary intervention study: Design, methods, and baseline characteristics☆John F. Brensike, Sheryl F. Kelsey, Eugene R. Passamani, Marian R. Fisher, John M. Richardson
Controlled Clinical Trials. 1982-06-01
Journal Articles
- A Dose-Dependent Increase in Mortality with Vesnarinone Among Patients with Severe Heart Failure.Vesnarinone Trial Investigators, New England Journal of Medicine
- Hobbs RE. Results of the ATLAS Study – high or low doses of ACE inhibitors for heart failure?ATLAS Trial Investigators, Cleve Clin J Med
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure.ATLAS Study Group, Circulation
- Join now to see all
Abstracts/Posters
- Moexipril Versus Captopril in Patients with Mild to Moderate Hypertension.Loh IK, Tenth Scientific Meeting of the American Society of Hypertension; New York Hilton/Towers, New York, NY
Lectures
- What You Need to Know About Preventing Cancer?Melissa Belle Ford, Director for Prevention and Early Detection, Univ of Texas, M.D. A...
- Relearning Optimism.Terry Paulson, Ph.D
- Television Report: The Prevention of Heart Disease -a five part series.the Ventura Heart Institute education and screening program; KEYT Evening News; Santa Barbara, CA
- Join now to see all
Other
- Innovations in pharmaceuticalsIK Loh, Street Journal
http://online.wsj.com/article/ - Radio Interview: Health Care Reform: Initiatives to reduce federal impediments to the delivery of health care.Loh IK
The White House, Washington - Risk Factors in Premature Coronary Disease (Interview by Deborah Norville)Loh IK, Guest
NBC Studios, New York
Authored Content
- ACC 2021: Convergence of Cardiovascular and Diabetic Therapies ContinueMay 2021
- Here's What ISCHEMIA Really MeansNovember 2019
- Here's What ISCHEMIA Really MeansNovember 2019
- We Don't Have to Just Accept Patients Taking Health SupplementsFebruary 2019
- We Don't Have to Just Accept Patients Taking Health SupplementsFebruary 2019
- Join now to see all
Press Mentions
- Dr. Loh: Medications and Pills for Weight LossMay 27th, 2023
- Tuesday, Jan 31 2023January 31st, 2023
- Dr. Loh: Oral Antivirals Can Help Treat COVID, but Needs Long-Term MonitoringNovember 27th, 2021
- Join now to see all
Committees
- Chair, Technology & Innovation Committee, California Chapter of American College of Cardiology 2019 - Present
- Member, Artificial Intelligence for Symptom Assessment; International Telecommunication Union; World Health Organization 2019 - Present
- Member, Executive Steering Committee of the National Health Policy Council 1993 - 1995
- Member, Amgen’s Institutional BioSafety Committee
- Member, State of California Department of Health Services Cardiovascular Disease Prevention Coalition
- Member, Manuscript Review Board and Ad Hoc Editor for the Journal of Clinical Outcomes Management
- Member, Expert Panel on Outcomes Evaluation and Research for the American Heart Association
- Member, Advisory Board Company/Cardiology Preeminence Roundtable based in Washington DC
- Executive Steering Committee member, West Lipid Association Board of Directors
- Charter Member, Lipidologists of Los Angeles
Research History
- Senior Consultant/Principal Investigator- CARE ACCESS RESEARCH2023 - Present
- Director & Principal InvestigatorVentura Heart Institute1985 - Present
- Principal InvestigatorCardiovascular trials for Westlake Medical Research2010 - 2017
- National Heart, Lung and Blood Institute at the National Institutes of Health (NIH)Intramural (Molecular Diseases/Lipid Metabolism Branch) and extramural (Cardiac Diseases Branch; Division of Heart and Vascular Diseases) divisions1974 - 1977
Professional Memberships
- Member
- Member
External Links
- Websitehttp://www.venturaheart.com
- LinkedIn Publichttp://www.linkedin.com/in/drirvloh
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: